Trial Profile
Analgesic effects of Ivabradine in healthy volunteers
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Feb 2022
Price :
$35
*
At a glance
- Drugs Ivabradine (Primary)
- Indications Angina pectoris; Arrhythmias; Coronary artery disease; Heart failure
- Focus Pharmacodynamics
- Sponsors Kissei Pharmaceutical
- 09 Feb 2022 Status changed from active, no longer recruiting to completed.
- 04 Dec 2018 Status changed from recruiting to active, no longer recruiting.
- 12 Mar 2014 New trial record